Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study

Table 7 Comparison of stool changes in groups before and after treatment according to the Bristol stool scale

After treatment		Before treatment			Kappa	P value
		Type 1, 2	Type 3, 4	Type 5-7
All patients	Type 1, 2	12 (35.3)	2 (9.1)	2 (6.9)	0.175	0.006
	Type 3, 4	18 (52.9)	16 (72.7)	19 (65.5)
	Type 5-7	4 (11.8)	4 (18.2)	8 (27.6)
Group 1	Type 1, 2	4 (23.5)	2 (14.3)	1 (8.3)	0.061	0.448
	Type 3, 4	12 (70.6)	10 (71.4)	9 (75.0)
	Type 5-7	1 (5.9)	2 (14.3)	2 (16.7)
Group 2	Type 1, 2	8 (47.1)	0 (0)	1 (5.9)	0.26	0.005
	Type 3, 4	6 (35.3)	6 (75.0)	10 (58.8)
	Type 5-7	3 (17.6)	2 (25.0)	6 (35.3)

Group 1: Low fermentable oligo, di- and monosaccharides and polyols (FODMAP) diet + probiotic, Group 2: low fermentable oligo, di- and monosaccharides and polyols diet + placebo.